| Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy CH Ries, MA Cannarile, S Hoves, J Benz, K Wartha, V Runza, ... Cancer cell 25 (6), 846-859, 2014 | 1293 | 2014 |
| T cell–induced CSF1 promotes melanoma resistance to PD1 blockade NJ Neubert, M Schmittnaegel, N Bordry, S Nassiri, N Wald, C Martignier, ... Science translational medicine 10 (436), eaan3311, 2018 | 266 | 2018 |
| Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors E Klopocki, G Kristiansen, PJ Wild, I Klaman, E Castanos-Velez, G Singer, ... International journal of oncology 25 (3), 641-649, 2004 | 212 | 2004 |
| Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin α2 as a potential novel prognostic marker in breast cancer E Dahl, G Kristiansen, K Gottlob, I Klaman, E Ebner, B Hinzmann, ... Clinical Cancer Research 12 (13), 3950-3960, 2006 | 189 | 2006 |
| Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like … CA Gomez-Roca, A Italiano, C Le Tourneau, PA Cassier, M Toulmonde, ... Annals of Oncology 30 (8), 1381-1392, 2019 | 136 | 2019 |
| Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1,-8 and-12 J Gröne, B Weber, E Staub, M Heinze, I Klaman, C Pilarsky, K Hermann, ... International journal of colorectal disease 22, 651-659, 2007 | 119 | 2007 |
| Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours D Mennerich, A Vogel, I Klaman, E Dahl, RB Lichtner, A Rosenthal, ... European Journal of Cancer 40 (9), 1373-1382, 2004 | 117 | 2004 |
| The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression G Kasper, A Vogel, I Klaman, J Gröne, I Petersen, B Weber, ... Cancer letters 224 (1), 93-103, 2005 | 112 | 2005 |
| ITIH5, a novel member of the inter-α-trypsin inhibitor heavy chain family is downregulated in breast cancer M Himmelfarb, E Klopocki, S Grube, E Staub, I Klaman, B Hinzmann, ... Cancer letters 204 (1), 69-77, 2004 | 106 | 2004 |
| An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types E Staub, J Groene, M Heinze, D Mennerich, S Roepcke, I Klaman, ... Journal of molecular medicine 87, 633-644, 2009 | 102 | 2009 |
| Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer E Dahl, A Sadr‐Nabavi, E Klopocki, B Betz, S Grube, R Kreutzfeld, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 76 | 2005 |
| Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression D Koensgen, A Mustea, I Klaman, P Sun, M Zafrakas, W Lichtenegger, ... Gynecologic oncology 107 (2), 266-273, 2007 | 58 | 2007 |
| Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III J Groene, U Mansmann, R Meister, E Staub, S Roepcke, M Heinze, ... International journal of cancer 119 (8), 1829-1836, 2006 | 56 | 2006 |
| Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients JP Machiels, C Gomez-Roca, JM Michot, D Zamarin, T Mitchell, G Catala, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 48 | 2020 |
| Expression and localization of e-cadherin in epithelial ovarian cancer D Koensgen, C Freitag, I Klaman, E Dahl, A Mustea, R Chekerov, I Braicu, ... Anticancer research 30 (7), 2525-2530, 2010 | 39 | 2010 |
| Altered Expression Pattern of Topoisomerase IIα, in Ovarian Tumor Epithelial and Stromal Cells after Platinum-Based Chemotherapy R Chekerov, I Klaman, M Zafrakas, D Könsgen, A Mustea, B Petschke, ... Neoplasia 8 (1), 38-45, 2006 | 39 | 2006 |
| Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour PA Cassier, A Italiano, C Gomez-Roca, C Le Tourneau, M Toulmonde, ... European Journal of Cancer 141, 162-170, 2020 | 38 | 2020 |
| Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis NB Serce, A Boesl, I Klaman, S von Serényi, E Noetzel, MF Press, ... BMC cancer 12, 1-13, 2012 | 30 | 2012 |
| Seamless virtual whole slide image synthesis and validation using perceptual embedding consistency A Lahiani, I Klaman, N Navab, S Albarqouni, E Klaiman IEEE Journal of Biomedical and Health Informatics 25 (2), 403-411, 2020 | 27 | 2020 |
| Virtualization of tissue staining in digital pathology using an unsupervised deep learning approach A Lahiani, J Gildenblat, I Klaman, S Albarqouni, N Navab, E Klaiman Digital Pathology: 15th European Congress, ECDP 2019, Warwick, UK, April 10 …, 2019 | 27 | 2019 |
